Chen, L. Y., Thibaud, S., Bodnar, S., Chari, A., Richter, J., Cho, H. J., . . . Jagannath, S. MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma. Elsevier.
Chicago Style (17th ed.) CitationChen, Lucia Y., et al. MRD-negative Duration Following Latest Line of Therapy Predicts Long-term PFS in Real-world Patients with Multiple Myeloma. Elsevier.
MLA (9th ed.) CitationChen, Lucia Y., et al. MRD-negative Duration Following Latest Line of Therapy Predicts Long-term PFS in Real-world Patients with Multiple Myeloma. Elsevier.
Warning: These citations may not always be 100% accurate.